- Home
- DERM
as 05-09-2025 4:00pm EST
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SCOTTSDALE |
| Market Cap: | 174.7M | IPO Year: | 2021 |
| Target Price: | $10.00 | AVG Volume (30 days): | 78.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.20 - $7.84 | Next Earning Date: | 05-20-2025 |
| Revenue: | $56,134,000 | Revenue Growth: | -29.11% |
| Revenue Growth (this year): | 29.83% | Revenue Growth (next year): | 54.88% |
Stock Insider Trading Activity of Journey Medical Corporation (DERM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Maraoui Claude | DERM | President & CEO | May 2 '25 | Sell | $6.84 | 4,834 | $33,064.56 | 2,348,313 | |
| Benesch Joseph | DERM | CFO | May 2 '25 | Sell | $6.84 | 2,409 | $16,477.56 | 203,557 | |
| Alloush Ramsey | DERM | COO | May 2 '25 | Sell | $6.84 | 2,857 | $19,541.88 | 504,817 | |
| Maraoui Claude | DERM | President & CEO | Mar 11 '25 | Sell | $5.01 | 49,271 | $246,847.71 | 2,348,313 | |
| Maraoui Claude | DERM | President & CEO | Mar 6 '25 | Sell | $5.03 | 40,456 | $203,451.09 | 2,348,313 | |
| Maraoui Claude | DERM | President & CEO | Mar 3 '25 | Sell | $5.12 | 70,556 | $360,761.67 | 2,348,313 | |
| Benesch Joseph | DERM | CFO | Feb 21 '25 | Sell | $5.19 | 1,365 | $7,084.35 | 203,557 |
Latest Journey Medical Corporation News
DERM Breaking Stock News: Dive into DERM Ticker-Specific Updates for Smart Investing
Zacks
a day ago
The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates
GlobeNewswire
2 days ago
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
Zacks
4 days ago
Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?
Insider Monkey
10 days ago
Why Journey Medical Corporation (DERM) is Surging in 2025
Zacks
17 days ago
Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?
Insider Monkey
21 days ago
Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?
Zacks
a month ago
Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?
MT Newswires
a month ago
Journey Medical Promotes Ramsey Alloush to COO
Compare DERM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DERM Journey Medical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.